ID

28066

Description

Study of Dasatinib and Bendamustine in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00872976

Link

https://clinicaltrials.gov/show/NCT00872976

Keywords

Versions (1)
  1. 12/14/17 12/14/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 14, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Lymphocytic Leukemia NCT00872976

English

Eligibility Chronic Lymphocytic Leukemia NCT00872976

1 forms  
Criteria
Description

Criteria

diagnosis of b-cll by nci criteria
Description

Chronic Lymphocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023434
require chemotherapy and have fully recovered from previous administered chemotherapy
Description

Chemotherapy Patient need for | Prior Chemotherapy Patient recovered

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0686904
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C1115804
subjects must have progressed, failed to achieve a meaningful response, or relapsed/intolerant to prior therapy. failing at least one purine analogue regimen
Description

Disease Progression | Response failed | Prior Therapy Recurrent disease | Prior Therapy intolerant | Purine analog Quantity failed

Data type

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C0231175
UMLS CUI [3,1]
C1514463
UMLS CUI [3,2]
C0277556
UMLS CUI [4,1]
C1514463
UMLS CUI [4,2]
C0231200
UMLS CUI [5,1]
C1268902
UMLS CUI [5,2]
C1265611
UMLS CUI [5,3]
C0231175
subjects have received three or fewer prior treatment regimens
Description

Prior Therapy Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1265611
ecog status of 0 - 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
inclusion criteria (cohort #2):
Description

Inclusion ceiteria Cohort Specified

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0599755
UMLS CUI [1,3]
C0205369
if dose level + 3 is reached, the criteria is the same as outlined for cohort #1, however the subjects should not have a history of prior chemotherapy (treatment naive)
Description

Dose level | Inclusion criteria Same | Prior Chemotherapy Absent | Therapy naive

Data type

boolean

Alias
UMLS CUI [1]
C0178602
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C0445247
UMLS CUI [3,1]
C1514457
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0919936
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
unwilling or unable to use an acceptable method to avoid pregnancy
Description

Contraceptive methods Unwilling | Contraceptive methods Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C1299582
uncontrolled or significant cardiovascular disease, including prolonged qtc interval
Description

Cardiovascular Disease Uncontrolled | Cardiovascular Disease | Prolonged QTc interval

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0007222
UMLS CUI [3]
C1560305
history of significant bleeding disorder, unrelated to cll
Description

Blood Coagulation Disorder | CLL Relationship Absent

Data type

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2,1]
C0023434
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C0332197
prior concurrent malignancy
Description

Cancer Other

Data type

boolean

Alias
UMLS CUI [1]
C1707251
drugs that generally accepted to have the risk of causing torsades de pointes
Description

Pharmaceutical Preparations At risk Torsades de Pointes

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C0040479
autoimmune hemolytic anemia requiring therapy or transfusion support
Description

Autoimmune hemolytic anemia Treatment required for | Autoimmune hemolytic anemia Requirement Support transfusion therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0002880
UMLS CUI [1,2]
C0332121
UMLS CUI [2,1]
C0002880
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0436311
autoimmune thrombocytopenia requiring steroid therapy or transfusion support
Description

Autoimmune thrombocytopenia Requirement Steroid therapy | Autoimmune thrombocytopenia Requirement Support transfusion therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0242584
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0149783
UMLS CUI [2,1]
C0242584
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0436311
richter's syndrome
Description

Richter's syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0349631
transformation to prolymphocytic leukemia
Description

Transformation Prolymphocytic Leukemia

Data type

boolean

Alias
UMLS CUI [1,1]
C4055129
UMLS CUI [1,2]
C0023486
Back to the top of the page

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00872976

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Chronic Lymphocytic Leukemia
Item
diagnosis of b-cll by nci criteria
boolean
C0023434 (UMLS CUI [1])
Chemotherapy Patient need for | Prior Chemotherapy Patient recovered
Item
require chemotherapy and have fully recovered from previous administered chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C1514457 (UMLS CUI [2,1])
C1115804 (UMLS CUI [2,2])
Disease Progression | Response failed | Prior Therapy Recurrent disease | Prior Therapy intolerant | Purine analog Quantity failed
Item
subjects must have progressed, failed to achieve a meaningful response, or relapsed/intolerant to prior therapy. failing at least one purine analogue regimen
boolean
C0242656 (UMLS CUI [1])
C1704632 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C1514463 (UMLS CUI [3,1])
C0277556 (UMLS CUI [3,2])
C1514463 (UMLS CUI [4,1])
C0231200 (UMLS CUI [4,2])
C1268902 (UMLS CUI [5,1])
C1265611 (UMLS CUI [5,2])
C0231175 (UMLS CUI [5,3])
Prior Therapy Quantity
Item
subjects have received three or fewer prior treatment regimens
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog status of 0 - 2
boolean
C1520224 (UMLS CUI [1])
Inclusion ceiteria Cohort Specified
Item
inclusion criteria (cohort #2):
boolean
C1512693 (UMLS CUI [1,1])
C0599755 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
Dose level | Inclusion criteria Same | Prior Chemotherapy Absent | Therapy naive
Item
if dose level + 3 is reached, the criteria is the same as outlined for cohort #1, however the subjects should not have a history of prior chemotherapy (treatment naive)
boolean
C0178602 (UMLS CUI [1])
C1512693 (UMLS CUI [2,1])
C0445247 (UMLS CUI [2,2])
C1514457 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0919936 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Contraceptive methods Unwilling | Contraceptive methods Unable
Item
unwilling or unable to use an acceptable method to avoid pregnancy
boolean
C0700589 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease | Prolonged QTc interval
Item
uncontrolled or significant cardiovascular disease, including prolonged qtc interval
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2])
C1560305 (UMLS CUI [3])
Blood Coagulation Disorder | CLL Relationship Absent
Item
history of significant bleeding disorder, unrelated to cll
boolean
C0005779 (UMLS CUI [1])
C0023434 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Cancer Other
Item
prior concurrent malignancy
boolean
C1707251 (UMLS CUI [1])
Pharmaceutical Preparations At risk Torsades de Pointes
Item
drugs that generally accepted to have the risk of causing torsades de pointes
boolean
C0013227 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0040479 (UMLS CUI [1,3])
Autoimmune hemolytic anemia Treatment required for | Autoimmune hemolytic anemia Requirement Support transfusion therapy
Item
autoimmune hemolytic anemia requiring therapy or transfusion support
boolean
C0002880 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0002880 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0436311 (UMLS CUI [2,3])
Autoimmune thrombocytopenia Requirement Steroid therapy | Autoimmune thrombocytopenia Requirement Support transfusion therapy
Item
autoimmune thrombocytopenia requiring steroid therapy or transfusion support
boolean
C0242584 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,3])
C0242584 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0436311 (UMLS CUI [2,3])
Richter's syndrome
Item
richter's syndrome
boolean
C0349631 (UMLS CUI [1])
Transformation Prolymphocytic Leukemia
Item
transformation to prolymphocytic leukemia
boolean
C4055129 (UMLS CUI [1,1])
C0023486 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial